Sept 10 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* PARADIGM BIOPHARMACEUTICALS LTD- CO'S FIRST INVESTIGATIONAL NEW DRUG APPLICATION HAS BEEN CLEARED BY US FDA WITHIN 30-DAY REVIEW PERIOD
Sept 10 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :
* PARADIGM BIOPHARMACEUTICALS LTD- CO'S FIRST INVESTIGATIONAL NEW DRUG APPLICATION HAS BEEN CLEARED BY US FDA WITHIN 30-DAY REVIEW PERIOD